Company Information

CIN
Status
Date of Incorporation
25 May 1990
Classes
Listing Status
Unlisted
Type
State
Mumbai
ROC
ROC Mumbai
Industry
Pharmaceutical And Botanical Products
Sub Category
Non-govt company
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2023
Paid Up Capital
2,199,800
Authorised Capital
105,000,000

Directors

Shirin Hamied
Shirin Hamied
Director/Designated Partner
for over 1 year
Srinivas Hariharan
Srinivas Hariharan
Director/Designated Partner
for over 1 year

Past Directors

Raman Parameswaran Athipotta
Raman Parameswaran Athipotta
Additional Director
almost 10 years ago
Vilas Gopal Khire
Vilas Gopal Khire
Whole Time Director
over 26 years ago

Trademarks

Mycotam Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Obetrex Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Gynut Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Duosal Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Okarubicin Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Okal Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Pirocam Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Docline Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Mediaid Okasa Pharma

[Class : 5] Pharmaceutical & Medical Preparation Included In Class 5.

Okacept Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Loranex Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Fexodin D Okasa Pharma

[Class : 5] Pharmaceutical And Medical Preparations.

Neocip Fc Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Ticlodin Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Metaday Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Okacet Ax Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Becloz Okasa Pharma

[Class : 5] Pharmaceutical And Medicinal Preparations.

Flotec Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Lamogin Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Codipain Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Gystrone Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Ciplox D Okasa Pharma

[Class : 5] Pharmaceutical & Medical Preparation

Okacarb Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Iflo Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Encard Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Nuquin Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Sybotrex Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Qucip Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Okanorm Mps Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Sibumine Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Doxasin Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Pirotec Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Valpro Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Levetec Okasa Pharma

[Class : 5] Pharmaceutical & Medicinal Preparation.

Mobix Okasa Pharma

[Class : 5] Pharmaceutical & Medicial Preparations.

Charges

0
16 November 2004
Axis Bank Limited
3 Crore
04 January 1993
The Saraswat Co Operative Bank Ltd
1 Crore
16 November 2004
Axis Bank Limited
0
04 January 1993
The Saraswat Co Operative Bank Ltd
0
16 November 2004
Axis Bank Limited
0
04 January 1993
The Saraswat Co Operative Bank Ltd
0

Documents

Form DPT-3-16122020-signed
Approval letter of extension of financial year of AGM-10102019
List of share holders, debenture holders;-10102019
Optional Attachment-(2)-10102019
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-10102019
Form AOC-4(XBRL)-10102019_signed
Form MGT-7-10102019_signed
Form ADT-1-04102019_signed
Copy of resolution passed by the company-04102019
Copy of written consent given by auditor-04102019
Copy of the intimation sent by company-04102019
Form BEN - 2-02082019_signed
Declaration under section 90-02082019
List of share holders, debenture holders;-03112018
Form MGT-7-03112018
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-24102018
Form AOC-4(XBRL)-24102018_signed
Form PAS-3-13102018_signed
Copy of Board or Shareholders? resolution-12102018
List of allottees. Attach separate list for each allotment (refer instruction kit for format).If not attached, then it shall be submitted separately in a CD.-12102018

Frequently Asked Questions

What is the date of Okasa pharma private limited incorporation?

Incorporation date of the company is 25 May 1990 .

Where are the documents of the company based?

The documents of the company are based in Mumbai.

Is the company legitimate or illegitimate company as per ROC data?

The company status as per MCA is Active.

What is the Number of directors in the company board?

Number of directors in the company board are 4.

Okasa pharma private limited has appointed how many directors?

The appointed directors in the company are:

  • Shirin hamied
  • Raman parameswaran athipotta
  • Srinivas hariharan
  • Vilas gopal khire